All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Corporate BondsHigh grade and crossover bonds

Sanofi follows Danaher's lead to tap recent bond through original pricing

Sanofi pharmaceutical laboratory research medicine from corp media gallery 575x375

Sanofi, the French pharmaceutical company, followed the example of Danaher by reopening bonds that priced in the last few weeks. It raised another €500m on Monday, pricing well inside where it priced the original bonds at the end of March.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login